Additionally, quercetin-treated BMSCs produce exosomes that deliver miR-124-3p to chondrocytes, inhibiting osteoarthritis progression by reversing the apoptotic effects of inflammatory cytokines and modulating key signaling pathways such as MAPK/p38 and NF-κB [130]. The gene discussed is NFKB1; the disease is osteoarthritis.